2014
DOI: 10.1016/j.jfo.2013.05.027
|View full text |Cite
|
Sign up to set email alerts
|

Rétinoblastome : résultats préliminaires du protocole national de prise en charge au CHU de Casablanca

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
6
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 13 publications
(7 citation statements)
references
References 16 publications
1
6
0
Order By: Relevance
“…Retinoblastoma is the most frequent childhood intraocular tumor with an approximately incidence of 1/15000-20000 birth in the world [ 1 ]. In north Africa, it is the most important ocular malignancy, It is bilateral in about 25-35% of cases [ 2 ]. The recent advances for early detection and treatment like identification of genetic mutations, use of chemoreduction to minimize the size of the tumor, identification of histopathologic high risk features following enucleation and provision of adjuvant therapy to reduce the incidence of systemic metastasis, and aggressive multimodal therapy in the management of orbital retinoblastoma have contributed to improve outcomes in terms of better survival [ 3 ].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Retinoblastoma is the most frequent childhood intraocular tumor with an approximately incidence of 1/15000-20000 birth in the world [ 1 ]. In north Africa, it is the most important ocular malignancy, It is bilateral in about 25-35% of cases [ 2 ]. The recent advances for early detection and treatment like identification of genetic mutations, use of chemoreduction to minimize the size of the tumor, identification of histopathologic high risk features following enucleation and provision of adjuvant therapy to reduce the incidence of systemic metastasis, and aggressive multimodal therapy in the management of orbital retinoblastoma have contributed to improve outcomes in terms of better survival [ 3 ].…”
Section: Introductionmentioning
confidence: 99%
“…Though it is a rare clinical presentation in developed countries ranging from 6.3% to 7.6% [ 7 ], it is not an unusual feature in developing and under developed world [ 8 ], mortality linked to orbital retinoblastoma in these countries is still high owing to late presentations compounded by socio-economic factors with the mortality reported as high as 50-90% [ 9 , 10 ]. Previous studies in morocco had reported epidemiological and clinical characteristics of retinoblastoma [ 2 , 3 ]. The aim of our study is to present data over three years about clinical presentation, therapeutic care and outcomes of children presenting orbital retinoblastoma treated at the Mohamed VI university hospital of Marrakech, which is a referral and tertiary care center in the south of morocco, to understand various reasons for the delayed presentation and to compare our results with those reported in the literature.…”
Section: Introductionmentioning
confidence: 99%
“…On the other hand, in a study carried out in Morocco in 2014, the rate of ocular conservative treatments was 85.7% and the rate survival was 81.2% at 5 years. It should also be noted that we have a fairly high loss of follow-up rate compared to other studies, including Senegal 11.9%[6] and Morocco 6.2%[17].…”
mentioning
confidence: 44%
“…These data from the literature correspond to our series where the overall survival rate at five years is 85.41%. The factors that worsen the prognosis are the size of the tumor and the extra-retinal extension with the invasion of the choroid, the sclera, or the optic nerve [ 9 ]. Thirteen or 9.02% of the patients in our series died.…”
Section: Discussionmentioning
confidence: 99%